Profile
Christine Murray currently works at Cytokinetics, Inc., as Senior Vice President-Regulatory & Quality from 2023.
Ms. Murray also formerly worked at Eiger BioPharmaceuticals, Inc., as Independent Director from 2019 to 2024, Achaogen, Inc., as Vice President-Regulatory Affairs from 2011 to 2015, Horizon Pharmaceutical LLC, as Vice President-Global Regulatory Affairs from 2015 to 2017, Raptor Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 2015 to 2017, and Ultragenyx Pharmaceutical, Inc., as Senior Vice President-Global Regulatory Affairs from 2018 to 2021.
Ms. Murray received her undergraduate degree from The University of Liverpool and graduate degree from Newcastle University.
Christine Murray active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | General Counsel | 01/04/2023 |
Former positions of Christine Murray
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Director/Board Member | 15/03/2024 |
| ULTRAGENYX PHARMACEUTICAL INC. | General Counsel | 01/09/2021 |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Corporate Officer/Principal | 01/02/2017 |
| RAPTOR PHARMACEUTICAL CORP | General Counsel | 01/01/2017 |
| ACHAOGEN | General Counsel | 02/01/2015 |
Training of Christine Murray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle University
Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
- Stock Market
- Insiders
- Christine Murray
















